Joshua J Gagne

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Urinary Tract Infection

Angiotensin Converting Enzyme

Finite Element Analysis

Drug Administration

Top Venues

Pharmacoepidemiology and drug safety

Statistics in medicine

American journal of epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Nazleen F Khan, Katsiaryna Bykov, Robert J Glynn, Seanna M Vine, Joshua J Gagne
Comparative risk of opioid overdose in patients who initiated antibiotics for urinary tract infection while on long-term opioid therapy. American journal of epidemiology (2024)
Suzanne M Cadarette, Malcolm Maclure, Joseph A Chris Delaney, Heather J Whitaker, Kaleen N Hayes, Shirley V Wang, Mina Tadrous, Joshua J Gagne, Giulia P Consiglio, Nina Sahlertz Kristiansen
Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology. Pharmacoepidemiology and drug safety 30 (6) (2021)
Nicolas H Thurin, Régis Lassalle, Martijn Schuemie, Marine Pénichon, Joshua J Gagne, Jeremy A Rassen, Jacques Benichou, Alain Weill, Patrick Blin, Nicholas Moore, Cécile Droz-Perroteau
Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS). Pharmacoepidemiology and drug safety 30 (3) (2020)
Mette Bliddal, Sören Möller, Christina Anne Vinter, Katrine Hass Rubin, Joshua J Gagne, Jesper Hallas
Validation of a comorbidity index for use in obstetric patients: A nationwide cohort study. Acta obstetricia et gynecologica Scandinavica 99 (3) (2019)
Joshua J Gagne, Jennifer R Popovic, Michael Nguyen, Sukhminder K Sandhu, Patty Greene, Rima Izem, Wenlei Jiang, Zhong Wang, Yueqin Zhao, Andrew B Petrone, Anita K Wagner, Sarah K Dutcher
Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs. Drug safety 41 (12) (2019)
Ivair R Silva, Joshua J Gagne, Mehdi Najafzadeh, Martin Kulldorff
Exact sequential analysis for multiple weighted binomial end points. Statistics in medicine 39 (3) (2019)
Andrew B Petrone, April DuCott, Joshua J Gagne, Sengwee Toh, Judith C Maro
The Devil's in the details: Reports on reproducibility in pharmacoepidemiologic studies. Pharmacoepidemiology and drug safety 28 (5) (2019)
Catherine A Panozzo, Emily C Welch, Tiffany S Woodworth, Ting-Ying Huang, Qoua L Her, Joshua J Gagne, Jenny W Sun, Catherine Rogers, Talia J Menzin, Max Ehrmann, Katherine E Freitas, Nicole R Haug, Sengwee Toh
Assessing the impact of the new ICD-10-CM coding system on pharmacoepidemiologic studies-An application to the known association between angiotensin-converting enzyme inhibitors and angioedema. Pharmacoepidemiology and drug safety 27 (8) (2018)
Shirley V Wang, Sebastian Schneeweiss, Marc L Berger, Jeffrey Brown, Frank de Vries, Ian Douglas, Joshua J Gagne, Rosa Gini, Olaf Klungel, C Daniel Mullins, Michael D Nguyen, Jeremy A Rassen, Liam Smeeth, Miriam Sturkenboom, null null
Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0. Pharmacoepidemiology and drug safety 26 (9) (2018)
Shirley V Wang, Martin Kulldorff, Robert J Glynn, Joshua J Gagne, Jesper Hallas, Kenneth J Rothman, Sebastian G Schneeweiss, Alexander Muir Walker
Reuse of data sources to evaluate drug safety signals: When is it appropriate? Pharmacoepidemiology and drug safety 27 (6) (2018)
David H Smith, Susan Shetterly, James Flory, Kevin Haynes, Christine Y Lu, Joshua J Gagne, Lisa Herrinton, Carsie Nyirenda, Elisabetta Patorno, Azadeh Shoaibi, Marsha A Raebel
Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease. Pharmacoepidemiology and drug safety 27 (8) (2018)
Elizabeth A Chrischilles, Joshua J Gagne, Bruce Fireman, Jennifer Nelson, Sengwee Toh, Azadeh Shoaibi, Marsha E Reichman, Shirley Wang, Michael Nguyen, Rongmei Zhang, Rima Izem, Margie R Goulding, Mary Ross Southworth, David J Graham, Candace Fuller, Hannah Katcoff, Tiffany Woodworth, Catherine Rogers, Ryan Saliga, Nancy D Lin, Cheryl N McMahill-Walraven, Vinit P Nair, Kevin Haynes, Ryan M Carnahan
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System. Pharmacoepidemiology and drug safety 27 (3) (2018)
Joshua J Gagne, Monika Houstoun, Marsha E Reichman, Christian Hampp, James H Marshall, Sengwee Toh
Safety assessment of niacin in the US Food and Drug Administration's mini-sentinel system. Pharmacoepidemiology and drug safety 27 (1) (2017)
Mallika L Mundkur, Kathryn Rough, Krista F Huybrechts, Raisa Levin, Joshua J Gagne, Rishi J Desai, Elisabetta Patorno, Niteesh K Choudhry, Brian T Bateman
Patterns of opioid initiation at first visits for pain in United States primary care settings. Pharmacoepidemiology and drug safety 27 (5) (2017)